# Rituxan in Churg Strauss Syndrome With Renal Involvement

> **NCT00424749** · PHASE2 · TERMINATED · sponsor: **Fernando Fervenza** · enrollment: 4 (actual)

## Conditions studied

- Churg-Strauss Syndrome

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00424749
- **Lead sponsor:** Fernando Fervenza
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Company providing study drug terminated study due to lack of funds
- **Last updated:** 2011-12-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424749, "Rituxan in Churg Strauss Syndrome With Renal Involvement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00424749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*